Diffusion Pharmaceuticals' Reverse Merger Round

Diffusion Pharmaceuticals raised a round of funding on December 28, 2015. Investors include Restorgenex Corporation.

Diffusion Pharmaceuticals is a clinical-stage company developing drugs which target the unmet medical needs characterized by oxygen deprivation (hypoxia) at the cellular level. These small molecules w…

Articles about Diffusion Pharmaceuticals' Reverse Merger Round: